Survival Outcomes and Prognostic Analysis Following Greater Cytoreductive Radiotherapy in Patients With Metastatic Prostate Cancer

Purpose: To assess the survival outcomes of patients with metastatic prostate cancer (mPCa) who undergo greater cytoreductive radiotherapy in a real-world clinical practice and determine their prognostic factors. Methods: We performed a retrospective study of 160 patients with mPCa who underwent cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zitong, Wei, Min, Mai, Lixin, Li, Yonghong, Wu, Jianhua, Huang, Hong, Huang, Sijuan, Lin, Maosheng, Jiang, Xiaobo, Zhou, Fangjian, Liu, Mengzhong, Liu, Yang, He, Liru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555263/
https://www.ncbi.nlm.nih.gov/pubmed/33102216
http://dx.doi.org/10.3389/fonc.2020.549220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555263/
https://www.ncbi.nlm.nih.gov/pubmed/33102216
http://dx.doi.org/10.3389/fonc.2020.549220

Ejemplares similares